Lantheus Alpha Therapy, LLC sold CATX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002064832-26-000314

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 1, 2026

Published

Sep 4, 2026

Ingested by INSIDER

Nov 5, 02:18 UTC

Last re-read

Nov 5, 02:18 UTC

Extracted facts

Filer

Lantheus Alpha Therapy, LLC

Role

10% Owner

Transaction

Open-market saleAs filed: “S”

Asset

Perspective Therapeutics, Inc.

Ticker

CATX

Shares

35.8K

Price per share

$3.12

Value

$111,574

Execution date (reported)

Sep 1, 2026

Owned after transaction

11.56M shares

Days from execution to publication

3

Calculation

What this establishes

Lantheus Alpha Therapy, LLC filed this Form 4 reporting a open-market sale of CATX on Sep 1, 2026. It became public on Sep 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

10% Owner

Lantheus Alpha Therapy, LLCcik:0002010224

Issuer

Perspective Therapeutics, Inc.cik:0000728387

Revision history · 0

No field has changed since this record was first ingested.